3, 2025 People with Type 2 diabetes who combined healthy lifestyle habits with GLP-1 receptor agonist (GLP-1 RA) medications had a greater reduction in risk of major adverse cardiovascular events, including heart attack, stroke or cardiovascular disease death, compared to people only taking the medication, according to a preliminary study to be presented at the American Heart Associations Scientific Sessions 2025
According to the annual KFF Employer Health Benefits Survey, coverage for obesity medications among very large employers rose to 43% this year, up from 28% last year
Therefore, additional studies are warranted to elucidate the influence of metabolic regulation on tumor immunology and enhance the efficacy of cancer immunotherapy
YN TM NHT, hy bm nt MUA HNG pha trn nh
If a GLP-1 patient experiences these GI complications, they need to seek immediate medical care and hospitalization
Weight loss shows up within the first month for most patients and continues over 6 to 12 months